4 hrs ago | Medical News
Studies outline dilemmas on new generic heart drugs, hormone replacement therapy
Better urban planning is key to improving health of 60% of global population that will be living in cities by 2030 One heart drug's move to generic status has complicated treatment options for some patients and doctors, the Wall Street Journal reports.
A Randomized, Double-Blind, Active-Controlled Phase 2 Trial to...
From the University of Alberta and Mazankowski Alberta Heart Institute, Edmonton, Alberta ; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC ; Institut fA1 4r Herzinfarktforschung, Ludwigshafen, Germany ; Third Medical Department, Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, Austria ; First Chair and ... (more)
Dr. Richard Hoffmann, Ask the Pharmacist, 05/29/12
A: On May 17, the U.S. Food and Drug Administration approved generic versions of the blood-thinning drug Plavix , which helps reduce the risk of heart attack and stroke by making it less likely platelets in the blood will clump and form clots in the arteries.
Heart Patients May Face a New Drug Dilemma
From time to time, we will send you e-mail announcements on new features and special offers from The Wall Street Journal Online.
Antiplatelet resistance and thromboembolic complications in neurointerventional procedures.
To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.
Clopidogrel Responsiveness in Stroke Patients on a Chronic Aspirin Regimen.
Platelet function was measured using 3 different "point-of-care" platelet function analyzers: the Thrombelastograph hemostasis system, the Accumetrics VerifyNow system, and the Chronolog 570VS impedance aggregometer.
Generic Plavix approved by FDA
The U.S. Food and Drug Administration has approved generic versions of the blood thinning drug Plavix for patients who have had a recent heart attack or a recent stroke, or have partial or total blockage of an artery .
Clinical and Pathological Improvement in Stroke-Prone Spontaneous...
Background and Purpose- Cerebral infarction is a major cause of death or decreasing activities of daily living.
Scientists turn skin cells into cardiac cells to help failing hearts
In a medical science first, researchers turned skin cells from heart failure patients into heart muscle cells that may then be used to fix damaged cardiac tissue.
Platelet Function Testing in Patients with Coronary Artery Disease:...
Antiplatelet therapy is one of the central pillars of treatment for patients with coronary artery disease.
HealthWarehouse.com Offers Consumers the Lowest Price on Generic PlavixA
CINCINNATI, May 22, 2012 /PRNewswire/ -- HealthWarehouse.com , Inc. a leading VIPPS*-accredited online retail mail-order pharmacy is now providing consumers with the lowest price option available for generic Plavix in the United States.
Newly Approved Generic Blood Thinner Saves Costs
The FDA recently approved the first ever generic version of the blood thinner Plavix.
Generic Launches Continue at Mylan
Analyst Report ), recently announced that it has received final approval from the U.S. Food & Drug Administration to launch generic versions of Plavix , 75 mg and 300 mg.
Generic Plavix arrives at Walmart and Sam's Club
Walmart has announced that it will be among the first retailers to offer Clopidogrel, the generic version of Plavix, at all Walmart and Sam's Club pharmacies.
Generic Versions Of Blood Thinning Plavix Approved By FDA
Generic versions of blood-thinning medication - Plavix - have been approved by the FDA .
FDA approves Plavix as a generic
A scientist for the French firm Sanofi-Aventis, which made and marketed the blood-thinner with Bristol-Myers Squibb.
Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.
FDA OKs Multiple Companies to Sell Generic Plavix as Drug Falls Off Patent Cliff
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Cheaper generic versions of blood thinner Plavix, the world's second-best-selling medicine, have just been approved for sale.
Benefits of widespread statin use outweigh risks
Many people know diabetes -- both type 1 and type 2 -- can take a serious toll on physical health.
Health roundup: Plavix goes generic
Generic Plavix: If you take the blood thinning drug Plavix, the cost of your medicine just dropped dramatically, from about $200 to $40 or less each month.
Also on Topix